Skip to main content
Log in

Short- and Long-Term Outcomes of Larynx-Preserving Surgery for Cervical Esophageal Cancer: Analysis of 100 Consecutive Cases

  • Head and Neck Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Surgical interventions for cervical esophageal cancer (CEC), particularly larynx-preserving procedures, have not yet been standardized in terms of short- and long-term outcome.

Methods

We retrospectively analyzed 100 consecutive surgeries for CEC in our department. We compared clinicopathological parameters and long-term outcomes between larynx-preserving esophagectomies (LP group) and nonpreserving procedures (NP group). We also evaluated preoperative predictive parameters for larynx-preservation.

Results

Compared with the NP group, the LP group had significantly lower cT (P < 0.001) and cStage (P = 0.001) and shorter tumor length (P = 0.0108). Multivariate logistic regression analysis identified early cT stage, early cStage, and response to preoperative treatment as significant predictive parameters of larynx preservation. Larynx-preserving procedures could be performed for 90.5 % of T1–2 tumors regardless of preoperative treatment response. In contrast in T3–4 tumors, most nonresponders (92.3 %) were ineligible for larynx-preservation (P = 0.0012), whereas 54.3 % of responders could achieve larynx preservation. The average shortening of upward extension in T3–4 tumors after preoperative treatment was 20.0 mm in the LP group vs. 10.2 mm in the NP group (P = 0.051). The two groups were similar in terms of overall morbidity (including pneumonia), mortality, and postoperative hospital days. Importantly, larynx preservation for CEC neither worsened patient prognosis nor increased locoregional recurrence compared to the NP group.

Conclusions

Larynx-preserving esophagectomy for CEC is feasible and oncologically acceptable. The cT, cStage, and clinical response to preoperative treatment are important preoperative predictors of a patient’s suitability for larynx-preservation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Laterza E, Mosciaro O, Urso US, Inaspettato G and Cordiano C. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepato Gastroenterology. 1994;41:278–82.

    CAS  PubMed  Google Scholar 

  2. Lee DJ, Harris A, Gillette A, Munoz L and Kashima H. Carcinoma of the cervical esophagus: diagnosis, management, and results. South. Med J. 1984;77:1365–7.

    Article  CAS  PubMed  Google Scholar 

  3. NCCN. National comprehensive cancer network clinical practice guidelines in oncology. National Comprehensive Cancer Network, Fort Washington. 2011.

  4. Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH. Current management of cervical esophageal cancer. World J Surg. 2011;35:600–7.

    Article  PubMed  Google Scholar 

  5. Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, et al. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol. 2006;1:252–9.

    Article  PubMed  Google Scholar 

  6. Uno T, Isobe K, Kawakami H, Ueno N, Shimada H, Matsubara H, et al. Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus. 2007;20:12–8.

    Article  CAS  PubMed  Google Scholar 

  7. Bidoli P, Bajetta E, Stani SC, De CD, Santoro A, Valente M, et al. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer. 2002;94:352–61.

    Article  PubMed  Google Scholar 

  8. Stuschke M, Stahl M, Wilke H, Walz MK, Oldenburg AR, Stuben G, et al. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology. 1999;57:99–105.

    Article  CAS  PubMed  Google Scholar 

  9. Wang HW, Chu PY, Kuo KT, Yang CH, Chang SY, Hsu WH, et al. A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol. 2006;93:468–76.

    Article  PubMed  Google Scholar 

  10. Ott K, Lordick F, Molls M, Bartels H, Biemer E and Siewert JR. Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg. 2009;96:258–66.

    Article  CAS  PubMed  Google Scholar 

  11. Kadota H, Sakuraba M, Kimata Y, Hayashi R, Ebihara S, Kato H. Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope. 2009;119:1274–80.

    Article  PubMed  Google Scholar 

  12. Sobin L GM, Wittekind C. TNM Classification of malignant tumours, 7th edn. New York: Wiley; 2009.

    Google Scholar 

  13. Makino T, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Nakajima K, et al. Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery. 2010;148:908–18.

    Article  PubMed  Google Scholar 

  14. Makino T, Doki Y, Miyata H, Yasuda T, Yamasaki M, Fujiwara Y, et al. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma. Surgery. 2008;144:793–802.

    Article  PubMed  Google Scholar 

  15. Miyata H, Yamasaki M, Takahashi T, Murakami K, Kurokawa Y, Nakajima K, et al. Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer. Br J Surg. 2013;100:1490–7.

    Article  CAS  PubMed  Google Scholar 

  16. Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, et al. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer. Ann Surg. 2011;253:279–84.

    Article  PubMed  Google Scholar 

  17. Yamasaki M, Miyata H, Tanaka K, Shiraishi O, Motoori M, Peng YF, et al. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus. Oncology. 2011;80:307–13.

    Article  CAS  PubMed  Google Scholar 

  18. Miyata H, Yamasaki M, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, et al. Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus. World J Surg. 2013;37:551–7.

    Article  PubMed  Google Scholar 

  19. Sun F, Li X, Lei D, Jin T, Liu D, Zhao H, et al. Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction. Int J Clin Exp Med. 2014;7:2771–8.

    PubMed  PubMed Central  Google Scholar 

  20. Shiozaki H, Tsujinaka T, Inoue M, Yano M, Doki Y, Miyaguchi M, et al. Larynx preservation in surgical treatment of cervical esophageal cancer: combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus. 2000;13:213–8.

    Article  CAS  PubMed  Google Scholar 

  21. Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, et al. Evaluation of dysphagia and diminished airway protection after three-field esophagectomy and a remedy. World J Surg. 2013;37:416–23.

    Article  PubMed  Google Scholar 

  22. Carlson GW, Schusterman MA and Guillamondegui OM. Total reconstruction of the hypopharynx and cervical esophagus: a 20-year experience. Ann Plast Surg. 1992;29:408–12.

    Article  CAS  PubMed  Google Scholar 

  23. Kakegawa T, Yamana H and Ando N. Analysis of surgical treatment for carcinoma situated in the cervical esophagus. Surgery. 1985;97:150–7.

    CAS  PubMed  Google Scholar 

  24. Mansour KA, Picone AL and Coleman JJ, 3rd. Surgery for high cervical esophageal carcinoma: experience with 11 patients. Ann Thorac Surg. 1990;49:597–601 (discussion 6012).

  25. Kelley DJ, Wolf R, Shaha AR, Spiro RH, Bains MS, Kraus DH, et al. Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg. 1995;170:427–31.

    Article  CAS  PubMed  Google Scholar 

  26. Triboulet JP, Mariette C, Chevalier D and Amrouni H. Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg. 2001;136:1164–70.

    Article  CAS  PubMed  Google Scholar 

  27. Shirakawa Y, Naomoto Y, Noma K, Ono R, Nobuhisa T, Kobayashi M, et al. Free jejunal graft for hypopharyngeal and esophageal reconstruction. Langenbeck’s Arch Surg. 2004;389:387–90.

    Article  Google Scholar 

  28. Bergquist H, Ejnell H, Fogdestam I, Mark H, Mercke C, Lundell L, et al. Functional long-term outcome of a free jejunal transplant reconstruction following chemoradiotherapy and radical resection for hypopharyngeal and proximal oesophageal carcinoma. Digest Surg. 2004;21:426–31 (discussion 4323).

  29. Daiko H, Hayashi R, Saikawa M, Sakuraba M, Yamazaki M, Miyazaki M, et al. Surgical management of carcinoma of the cervical esophagus. J Surg Oncol. 2007;96:166–72.

    Article  PubMed  Google Scholar 

  30. Ferahkose Z, Bedirli A, Kerem M, Azili C, Sozuer EM and Akin M. Comparison of free jejunal graft with gastric pull-up reconstruction after resection of hypopharyngeal and cervical esophageal carcinoma. Dis Esophagus. 2008;21:340–5.

    Article  CAS  PubMed  Google Scholar 

  31. Grass GD, Cooper SL, Armeson K, Garrett-Mayer E and Sharma A. Cervical esophageal cancer: a population-based study. Head Neck. 2015;37:808–14.

    Article  PubMed  Google Scholar 

  32. Huang SH, Lockwood G, Brierley J, Cummings B, Kim J, Wong R, et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Rad Oncol Biol Phys. 2008;71:735–40.

    Article  CAS  Google Scholar 

  33. Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, et al. Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol. 2006;45:1120–5.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

There are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomoki Makino MD, PhD.

Electronic supplementary material

Below is the link to the electronic supplementary material.

10434_2016_5511_MOESM1_ESM.tif

Supplementary material 1 (TIFF 181 kb) Supplemental Fig. 1 Overall survival by classified cT (A) and cStage (B) compared between larynx-preserving versus nonpreserving procedures

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Makino, T., Yamasaki, M., Miyazaki, Y. et al. Short- and Long-Term Outcomes of Larynx-Preserving Surgery for Cervical Esophageal Cancer: Analysis of 100 Consecutive Cases. Ann Surg Oncol 23 (Suppl 5), 858–865 (2016). https://doi.org/10.1245/s10434-016-5511-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5511-x

Keywords

Navigation